194 related articles for article (PubMed ID: 22932468)
1. [Lynch syndrome-related endometrial carcinoma].
Pang SJ; Guo DH
Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):494-7. PubMed ID: 22932468
[No Abstract] [Full Text] [Related]
2. Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger.
Shih KK; Garg K; Levine DA; Kauff ND; Abu-Rustum NR; Soslow RA; Barakat RR
Gynecol Oncol; 2011 Oct; 123(1):88-94. PubMed ID: 21742371
[TBL] [Abstract][Full Text] [Related]
3. [Recent advances and future development on Lynch syndrome-associated endometrial cancer].
Ning Y; Wang Y; Wang YY; Zheng WX
Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):505-8. PubMed ID: 24246913
[No Abstract] [Full Text] [Related]
4. MMR deficiency is common in high-grade endometrioid carcinomas and is associated with an unfavorable outcome.
Nelson GS; Pink A; Lee S; Han G; Morris D; Ogilvie T; Duggan MA; Köbel M
Gynecol Oncol; 2013 Nov; 131(2):309-14. PubMed ID: 23938375
[TBL] [Abstract][Full Text] [Related]
5. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
[TBL] [Abstract][Full Text] [Related]
6. Preoperative diagnosis of Lynch syndrome with DNA mismatch repair immunohistochemistry on a diagnostic biopsy.
Warrier SK; Trainer AH; Lynch AC; Mitchell C; Hiscock R; Sawyer S; Boussioutas A; Heriot AG
Dis Colon Rectum; 2011 Dec; 54(12):1480-7. PubMed ID: 22067175
[TBL] [Abstract][Full Text] [Related]
7. Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients.
Walsh MD; Cummings MC; Buchanan DD; Dambacher WM; Arnold S; McKeone D; Byrnes R; Barker MA; Leggett BA; Gattas M; Jass JR; Spurdle AB; Young J; Obermair A
Clin Cancer Res; 2008 Mar; 14(6):1692-700. PubMed ID: 18310315
[TBL] [Abstract][Full Text] [Related]
8. In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response.
Meijer TW; Hoogerbrugge N; Nagengast FM; Ligtenberg MJ; van Krieken JH
Histopathology; 2009 Oct; 55(4):414-22. PubMed ID: 19817892
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemistry for mismatch repair protein deficiency in endometrioid endometrial carcinoma yields equivalent results when performed on endometrial biopsy/curettage or hysterectomy specimens.
Chapel DB; Yamada SD; Cowan M; Lastra RR
Gynecol Oncol; 2018 Jun; 149(3):570-574. PubMed ID: 29656794
[TBL] [Abstract][Full Text] [Related]
10. Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables.
Joehlin-Price AS; Perrino CM; Stephens J; Backes FJ; Goodfellow PJ; Cohn DE; Suarez AA
Gynecol Oncol; 2014 Apr; 133(1):43-7. PubMed ID: 24444820
[TBL] [Abstract][Full Text] [Related]
11. Tumor Screening and DNA Testing in the Diagnosis of Lynch Syndrome.
Usha L; Dewdney SB; Buckingham LE
JAMA; 2016 Jul; 316(1):93-4. PubMed ID: 27380347
[No Abstract] [Full Text] [Related]
12. Screening to detect Lynch syndrome and prevent hereditary cancers in relatives.
Haddow JE; Palomaki GE
J Med Screen; 2011; 18(4):167-8. PubMed ID: 22184732
[No Abstract] [Full Text] [Related]
13. Lynch syndrome in women less than 50 years of age with endometrial cancer.
Matthews KS; Estes JM; Conner MG; Manne U; Whitworth JM; Huh WK; Alvarez RD; Straughn JM; Barnes MN; Rocconi RP
Obstet Gynecol; 2008 May; 111(5):1161-6. PubMed ID: 18448750
[TBL] [Abstract][Full Text] [Related]
14. Interobserver variability in the evaluation of mismatch repair protein immunostaining.
Klarskov L; Ladelund S; Holck S; Roenlund K; Lindebjerg J; Elebro J; Halvarsson B; von Salomé J; Bernstein I; Nilbert M
Hum Pathol; 2010 Oct; 41(10):1387-96. PubMed ID: 20573374
[TBL] [Abstract][Full Text] [Related]
15. Prospective evaluation of DNA mismatch repair protein expression in primary endometrial cancer.
Backes FJ; Leon ME; Ivanov I; Suarez A; Frankel WL; Hampel H; Fowler JM; Copeland LJ; O'Malley DM; Cohn DE
Gynecol Oncol; 2009 Sep; 114(3):486-90. PubMed ID: 19515405
[TBL] [Abstract][Full Text] [Related]
16. Comparison of clinical schemas and morphologic features in predicting Lynch syndrome in mutation-positive patients with endometrial cancer encountered in the context of familial gastrointestinal cancer registries.
Ryan P; Mulligan AM; Aronson M; Ferguson SE; Bapat B; Semotiuk K; Holter S; Kwon J; Kalloger SE; Gilks CB; Gallinger S; Pollett A; Clarke BA
Cancer; 2012 Feb; 118(3):681-8. PubMed ID: 21721000
[TBL] [Abstract][Full Text] [Related]
17. Significant frequency of MSH2/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas.
Rambau PF; Duggan MA; Ghatage P; Warfa K; Steed H; Perrier R; Kelemen LE; Köbel M
Histopathology; 2016 Aug; 69(2):288-97. PubMed ID: 26799366
[TBL] [Abstract][Full Text] [Related]
18. Role of endometrial cancer abnormal MMR protein in screening Lynch-syndrome families.
Long Q; Peng Y; Tang Z; Wu C
Int J Clin Exp Pathol; 2014; 7(10):7297-303. PubMed ID: 25400828
[TBL] [Abstract][Full Text] [Related]
19. PMS2 involvement in patients suspected of Lynch syndrome.
Niessen RC; Kleibeuker JH; Westers H; Jager PO; Rozeveld D; Bos KK; Boersma-van Ek W; Hollema H; Sijmons RH; Hofstra RM
Genes Chromosomes Cancer; 2009 Apr; 48(4):322-9. PubMed ID: 19132747
[TBL] [Abstract][Full Text] [Related]
20. Mismatch repair gene deficiency and genetic anticipation in Lynch syndrome: myth or reality?
Ponti G; Ruini C; Tomasi A
Dis Colon Rectum; 2015 Jan; 58(1):141-2. PubMed ID: 25489705
[No Abstract] [Full Text] [Related]
[Next] [New Search]